We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Molecular Assay Assesses Asymptomatic Malaria

By LabMedica International staff writers
Posted on 03 Jan 2012
Print article
In malaria endemic areas, molecular techniques allow a more accurate assessment of the asymptomatic parasite burden in the local population.

In these areas, individuals frequently have no symptoms and go undetected by conventional microscopy or newer, rapid diagnostic tests (RDTs), but the parasites can be detected by polymerase chain reaction (PCR).

A study was carried out under the auspices of the London School of Hygiene and Tropical Medicine (UK), in a region of northeastern Tanzania to determine the relative prevalence of submicroscopic level parasite carriage and clonal complexity of infections over a range of endemicities. This study used 1,121 blood samples collected from a previously conducted cross-sectional malariometric survey during the short rainy season in 2001 from 13 villages at three different altitudes. Samples were analyzed by PCR for carriage of parasites and multiplicity of infection. The data was compared with other measures of transmission intensity collected from the same area. The PCR was carried out in a tetrad thermo-cycler (PTC-0240, The DNA engine Tetrad2 Thermal Cycler, Bio-Rad; Hercules, CA, USA), followed by gel electrophoresis to assign individuals as either parasite positive or negative.

A 2.5-fold difference was observed when parasite prevalence was compared between PCR at 34.7% and 13.6% by microscopy. This fold difference was relatively consistent at the different altitude bands despite a marked decrease in parasite prevalence with altitude. Multiplicity of infection (MOI) ranged from 1.2 to 3.7 and was positively associated with parasite prevalence assessed by both PCR and microscopy. There was no association of MOI and age. The difference between parasite prevalence by PCR was 3.2 in individuals aged between 15 and 45 years compared with 2.5 in those aged from one to five years.

The authors concluded that a large number of individuals carried submicroscopic parasites in a malaria endemic area of Tanzania and they are a potential reservoir of infection in the population. These infections are important as potential contributors to the infectious reservoir of parasites and need to be identified by control programs especially in this era where malaria elimination is a focus. High throughput standardized PCR approaches are needed to identify individuals who are malaria carriers. The study was published online on December 16 2011 in the Malaria Journal.

Related Links:

London School of Hygiene and Tropical Medicine
Bio-Rad


Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
Verification Panels for Assay Development & QC
Seroconversion Panels
New
TORCH Infections Test
TORCH Panel

Print article

Channels

Clinical Chemistry

view channel
Image: The study demonstrated that electric-field molecular fingerprinting can probe cancer (Photo courtesy of ACS Central Science, 2025, 10.1021/acscentsci.4c02164)

New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma

Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read more

Molecular Diagnostics

view channel
Image: The test monitors blood levels of DNA fragments released by dying tumor cells (Photo courtesy of 123RF)

Gene-Based Blood Test Accurately Predicts Tumor Recurrence of Advanced Skin Cancer

Melanoma, an aggressive form of skin cancer, becomes extremely difficult to treat once it spreads to other parts of the body. For patients with metastatic melanoma tumors that cannot be surgically removed... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.